Drug reference
tofacitinib
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Drug class
Musculoskeletal (TNF-alpha Inhibitors)
Mechanism of action
Janus kinases (JAKs) pathways inhibitor; JAK consists of a group of intracellular tyrosine kinases that transmit signals from cytokine or growth factor-receptor interactions on the cellular membrane to influence cellular processes of hematopoieses and immune cell function
Common side effects
- Upper respiratory tract infection
- Nasopharyngitis
- Headache
- Elevated cholesterol levels
- Diarrhea
Related conditions
Frequently asked questions
What drug class is tofacitinib?
tofacitinib belongs to: Musculoskeletal.
How does tofacitinib work?
Janus kinases (JAKs) pathways inhibitor; JAK consists of a group of intracellular tyrosine kinases that transmit signals from cytokine or growth factor-receptor interactions on the cellular membrane to influence cellular processes of hematopoieses and immune cell function
What are the common side effects of tofacitinib?
Upper respiratory tract infection, Nasopharyngitis, Headache, Elevated cholesterol levels, Diarrhea
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.